TP53 and glioblastoma: ITZ, an antifungal that has been shown to suppress the growth of GBM through the induction of autophagy, produced a low response in GBMs with variants in the ATRX, TP53, PTEN, PIK3CA and CDKN2A genes (Figure 3A).